
Chester County-based Biopharmaceutical Company Shares Positive Data from Pancreatic Cancer Treatment Trial
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced the release of the abstract containing interim data from the first 19 patients in its pilot Phase 1/2 clinical trial designed …
Read More